As of May, Ozempic and Wegovy remain on the FDA’s list of drug shortages. The drugs manufactured by Novo Nordisk include brands Ozempic and Rybelsus, used to treat diabetes, and Wegovy, approved to treat obesity.ĭemand for the medications has outstripped supply. Sales of semaglutide products have soared in the past few years after the drug was shown to spur fast and significant weight loss. Insight by Verizon: Can agencies create CX that’s ‘simplistic, delightful and surprising’? Leaders from the Agriculture Department, Education Department, Homeland Security Department and IRS think so and share the work underway in their agencies to make it easy to navigate government services. “Compounded drugs are not FDA-approved, and the agency does not verify the safety or effectiveness of compounded drugs,” the notice said. The trouble is that those versions, often sold online, contain a version of semaglutide that is used in lab research and has not been approved for use in people. Officials didn’t say what the problems were. Officials.Īgency officials said this week that they have received reports of problems after patients used versions of semaglutide, the active ingredient in the brand-name medications, which have been compounded, or mixed in pharmacies. Food and Drug Administration is warning consumers not to use off-brand versions of the popular weight-loss drugs Ozempic and Wegovy because they might not contain the same ingredients as the prescription products and may not be safe or effective.Īgency officials said this week that they have received reports of problems after patients used versions of semaglutide, the active ingredient in the brand-name medications, which have been compounded, or mixed in pharmacies.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |